Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127115432 | 12711543 | 2 | F | 20160912 | 20160902 | 20160914 | EXP | US-GILEAD-2016-0228826 | GILEAD | 85.00 | YR | E | F | Y | 83.36000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127115432 | 12711543 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10 MG, QD | 1509507A | 22081 | 10 | MG | TABLET | QD | |||||
| 127115432 | 12711543 | 2 | SS | PROCARDIA | NIFEDIPINE | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 127115432 | 12711543 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 127115432 | 12711543 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
| 127115432 | 12711543 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127115432 | 12711543 | 6 | C | ADCIRCA | TADALAFIL | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 7 | C | COUMADINE | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 8 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 10 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 11 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 14 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 127115432 | 12711543 | 15 | C | SILVER SULFADIAZINE. | SILVER SULFADIAZINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127115432 | 12711543 | 1 | Pulmonary arterial hypertension |
| 127115432 | 12711543 | 2 | Product used for unknown indication |
| 127115432 | 12711543 | 3 | Product used for unknown indication |
| 127115432 | 12711543 | 4 | Product used for unknown indication |
| 127115432 | 12711543 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127115432 | 12711543 | OT |
| 127115432 | 12711543 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127115432 | 12711543 | Acute kidney injury | |
| 127115432 | 12711543 | Cardiac failure | |
| 127115432 | 12711543 | Generalised oedema | |
| 127115432 | 12711543 | Hypotension | |
| 127115432 | 12711543 | Life expectancy shortened |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127115432 | 12711543 | 1 | 201604 | 0 |